Encompass Health Corp/ US29261A1007 /
31.05.2024 21:57:13 | Diff. +0,78 | Volumen | Geld22:25:00 | Brief22:25:00 | Marktkapitalisierung | Dividendenr. | KGV |
---|---|---|---|---|---|---|---|
86,38USD | +0,91% | 17.302 Umsatz: 612.924,16 |
-Geld Vol: - | -Brief Vol: - | 8,7 Mrd.USD | 0,69% | 24,61 |
Aktiva
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Sachanlagen | 1.517,1000 | 1.634,8000 | 1.959,3000 | 2.206,6000 | 2.601,6000 | ||||||
Immaterielle Vermögensgegenstände | 403,1000 | 443,4000 | 476,3000 | 431,3000 | 417,5000 | ||||||
Finanzanlagen | - | - | - | - | - | ||||||
Anlagevermögen | 4.191,5000 | 4.512,9000 | 5.324,9000 | 5.497,3000 | 5.943,5000 | ||||||
Vorräte | - | - | - | - | - | ||||||
Forderungen | 472,1000 | 467,7000 | 506,1000 | 572,8000 | 680,3000 | ||||||
Liquide Mitteln | 54,4000 | 69,2000 | 94,8000 | 224 | 54,8000 | ||||||
Umlaufvermögen | 702,2000 | 662,1000 | 755,8000 | 948,6000 | 921,4000 | ||||||
Aktiva, gesamt | 4.893,7000 | 5.175 | 6.080,7000 | 6.445,9000 | 6.864,9000 |
Passiva
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Verbindlichkeiten aus Lieferungen und Leistungen | 78,4000 | 90 | 94,6000 | 115 | 137,6000 | ||||||
Langfristige Schulden | 2.545,4000 | 2.478,6000 | 3.023,3000 | 3.250,6000 | 3.243,9000 | ||||||
Verbindlichkeiten gegenüber Kreditinstituten | 2.545,4000 | 2.478,6000 | 3.023,3000 | 3.250,6000 | 3.243,9000 | ||||||
Rückstellungen | - | - | - | 51,8000 | 86,7000 | ||||||
Verbindlichkeiten | 3.469,1000 | 3.618 | 4.387,6000 | 4.475,9000 | 4.507,9000 | ||||||
Gezeichnetes Kapital | 1,1000 | 1,1000 | 1,1000 | 1,1000 | 1,1000 | ||||||
Eigenkapital | 1.424,6000 | 1.557 | 1.693,1000 | 1.970 | 2.357 | ||||||
Minderheitenanteile | 242,9000 | 280,3000 | 340,9000 | 382 | 445,7000 | ||||||
Passiva, gesamt | 4.893,7000 | 5.175 | 6.080,7000 | 6.445,9000 | 6.864,9000 |
Gewinn- und Verlustrechnung
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Umsatzerlöse | 3.971,4000 | 4.277,3000 | 4.605 | 4.644,4000 | 5.121,6000 | ||||||
Abschreibungen (Gesamt) | 183,8000 | 199,7000 | 218,7000 | 243 | 256,6000 | ||||||
Betriebsergebnis | - | - | - | - | - | ||||||
Zinsergebnis | 154,4000 | 147,3000 | 159,7000 | 184,2000 | 164,6000 | ||||||
Ergebnis vor Steuern | 496,4000 | 493,2000 | 562,3000 | 472,6000 | 657,2000 | ||||||
Ertragsteuern | 160,6000 | 118,9000 | 115,9000 | 103,8000 | 139,6000 | ||||||
Gewinnanteil Minderheitsgesellschafter | -79,1000 | -83,1000 | -87,1000 | -84,6000 | -105 | ||||||
Konzernjahresüberschuss | 256,3000 | 292,3000 | 358,7000 | 284,2000 | 412,2000 |
Pro Aktie
Cash Flow
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow aus laufender Geschäftstätigkeit | 657,2000 | 762,4000 | 635,3000 | 704,7000 | 715,8000 | ||||||
Cash Flow aus Investitionstätigkeit | -284,5000 | -424,5000 | -657,4000 | -407,5000 | -666,3000 | ||||||
Cash Flow aus Finanzierungstätigkeit | -358,8000 | -321,2000 | 48,2000 | -145,9000 | -240,1000 | ||||||
Veränderung der liquiden Mittel | 13,9000 | 16,7000 | 26,1000 | 151,3000 | -190,6000 | ||||||
Anzahl der Mitarbeiter | 29.370 | 30.060 | 31.570 | 43.178 | 43.400 |